Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001–14: a case only analysis

Abstract

Summary Background Policies for early detection of breast cancer, including clinical breast examinations and mammographic screening, were introduced in Brazil in 2004, but their effect on disease stage at diagnosis is unclear. We aimed to assess whether these policies have led to a decrease in the prevalence of late-stage breast cancer at diagnosis. Methods In this case only analysis, using an anonymised nationwide hospital based-cancer registry network, we identified women aged 18–89 years who had been diagnosed with an invasive breast cancer in Brazil during 2001–14. We extracted individual patient-level data on patient demographics, tumour variables, and health-care provider variables for the centre where the patient was diagnosed. Our objectives were to estimate the prevalence of late-stage breast cancer (TNM stage III or IV) at diagnosis overall, across age groups, and by ethnoracial and social strata (ie, self-reported ethnoracial group, as white, black, brown, Asian, or Indigenous, and educational level, marital status, and region of residence) across the study period, and compare these estimates with international data from high-income countries (Norway and the USA). We used logistic regression to estimate odds ratios (ORs) for late-stage versus early-stage (TNM stage I or II) breast cancer at diagnosis in relation to relevant exposures, either minimally adjusted (for age, year of diagnosis, and region of residence) or fully adjusted (for all patient, tumour, and health-care provider variables). Findings We identified 247 719 women who were diagnosed with invasive breast cancer between Jan 1, 2001, and Dec 31, 2014, with a mean age at diagnosis of 55·4 years (SD 13·3), of whom 36·2% (n=89 550) identified as white, 29·8% (n=73 826) as black or brown, and 0·7% (n=1639) as Asian or Indigenous. Prevalence of late-stage breast cancer at diagnosis remained high throughout 2001–14, at approximately 40%, was inversely associated with educational level (p value for linear trend <0·0001), and was higher for women who identified as black (minimally adjusted OR 1·61, 95% CI 1·53–1·70; fully adjusted OR 1·45, 95% CI 1·38–1·54) and brown (minimally adjusted OR 1·26, 95% CI 1·22–1·30; fully adjusted OR 1·18, 1·14–1·23) than those who identified as white. The predicted prevalence of late-stage cancer at diagnosis was highest for women who were black or brown with little or no formal education (48·8%, 95% CI 48·2–49·5) and lowest for women who were white with university education (29·4%, 28·2–30·6), but both these prevalences were higher than that of all women diagnosed with breast cancer in Norway before the introduction of mammography screening (ie, 16·3%, 95% CI 15·4%–17·2% in 1970–74). Similar ethnoracial and social patterns emerged in analyses restricted to the age group targeted by screening (50–69 years). Interpretation The persistently high prevalence of late-stage breast cancer at diagnosis across a...

Breast cancer early detection: A phased approach to implementation

“…It was estimated that, in 2012, 2500 breast cancer deaths could have been averted by effective mammographic screening. However, it was estimated that, if from 50% to 80% of patients diagnosed at stage III or IV in the previous 5 years had been downstaged to stage II, then 8000 deaths could have been prevented 23 . Those authors concluded that clinical downstaging would have a greater effect than mammographic screening on breast cancer deaths for settings in which women present with late‐stage disease.…”

<p>Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy</p>

“…14,17,18 In terms of the clinical and epidemiological aspects, the patients with breast cancer included in this study mirror the distribution of this disease in Brazil and in the rest of the world. 19 Conversely, contrary to the trend in developed countries of diagnosing breast cancer in its initial stages, most patients included in this study received a disease diagnosis at a more advanced stage, which unfortunately reflects the specific practices of the public health system in the country. 20 More than 90% of the cases were diagnosed with invasive carcinoma of a nonspecific type, which is consistent with the findings described in the literature.…”

Breast cancer patient advocacy: A qualitative study of the challenges and opportunities for civil society organizations in low‐income and middle‐income countries

“…A health system's ability to manage symptomatic disease is a prerequisite to introducing screening programs 20 . Hence, the initial focus of any breast cancer control program should be on the downstaging and timely diagnosis of symptomatic breast cancer linked to accessible treatment, rather than on screening asymptomatic women 13,21 . Until the target health system that can downstage at least 50% of breast diagnoses from stage III and/or IV to stage II at the time of diagnosis is reached, programs should focus on the timely diagnosis of symptomatic breast cancer and improving referral pathways to effective and timely treatment rather than on screening for asymptomatic disease 5 …”